×
Business / Stock Market

ALT Stock: One Analyst Still Thinks Altimmune Prices Could Hit $34

Published Sep 28 2021 at 6:15 PM GMT
Investor Place

Investor Place @investorplace.com

Continue reading at investorplace.com
Key
Points
  • InvestorPlace - Stock Market News, Stock Advice & Trading Tips Some clinical trial results released by Altimmune have shareholders rushing to sell.
  • But, one analyst sees plenty of upside for ALT stock.
Credit
Tags
Continue reading at investorplace.com
Trending

Stats

  • Published Sep 28, 2021 6:15 PM GMT